Session Information
ENDO 2010 Annual Meeting - Includes 5 Complimentary Sessions
Click here to go to the previous page
CLINICAL - Nonglycemic Interventions To Reduce Microvascular Complications in Diabetes
Track
:
CLINICAL
Program Code:
S49
Date:
Monday, June 21, 2010
Time:
9:30 AM to 11:00 AM
EST
Location:
31ABC
SPEAKER
(S):
Lloyd P. Aiello, MD, PhD, Joslin Diabetes Ctr, Boston, MA
Disclosure: Consultant, Eli Lilly & Co, Genentech, Inc., Genzyme Corporation, Merck & Co, Novartis Pharmaceuticals, Pfizer, Inc; Advisory Group Member, Genentech, Inc., Genzyme Corporation.
Disclosure: Consultant, Eli Lilly & Co, Genentech, Inc., Genzyme Corporation, Merck & Co, Novartis Pharmaceuticals, Pfizer, Inc; Advisory Group Member, Genentech, Inc., Genzyme Corporation.
Ronald Klein, M.D., M.P.H., Univ of Wisconsin, Madison, WI
Disclosure: Advisory Group Member, AstraZeneca, Takeda; Consultant, Genentech, Inc., GlaxoSmithKline, Pfizer, Inc.
Disclosure: Advisory Group Member, AstraZeneca, Takeda; Consultant, Genentech, Inc., GlaxoSmithKline, Pfizer, Inc.
Eliot Brinton, MD, Univ of Utah, Salt Lake City, UTDisclosure: Speaker Bureau Member, Abbott Laboratories, AstraZeneca, GlaxoSmithKline, Merck & Co., Takeda; Study Investigator, Merck & Co.; Principal Investigator, Abbott Laboratories; Consultant, Abbott Laboratories, AstraZeneca, GlaxoSmithKline, Merck & Co., Takeda
No items are available for this session.